Success Story: No RFE! We Helped a Chinese Postdoctoral Fellow Secure NIW Success Smoothly

Client’s Testimonial:

“Thank you so much for the team’s help!”

On February 25^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Immunology (Approval Notice).

General Field: Immunology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: China

State of Residence at the Time of Filing: California

Approval Notice Date: February 25^th, 2025

Processing Time: 15 months, 17 days

Case Summary:

We are pleased to announce the approval of an EB-2 National Interest Waiver (NIW) petition for a highly accomplished researcher in the field of immunology. The petition was filed in November 2023 and approved in February 2025 without RFE issues.

Research Focus and Proposed Endeavor:
With a Ph.D. in molecular and cellular biology, the client has dedicated her career to advancing cancer research. Her proposed endeavor is to continue identifying and characterizing novel genes and pathways that influence tumor cell behavior, with the goal of improving our understanding of cancer pathogenesis and immunotherapy. Her work holds strong potential to accelerate the development of new therapeutic strategies that enhance treatment outcomes for cancer patients in the United States and beyond.

Scholarly Contributions and Impact:
The client has produced a notable body of research, including 8 peer-reviewed journal articles (with 1 first-authored) and 1 patent. Her scholarly work has been cited 124 times according to Google Scholar, reflecting its impact and recognition within the scientific community. Independent researchers have drawn upon her findings to further investigations into tumor immunology, gene expression, and therapeutic development, demonstrating the broad influence of her work.

Funding and Research Support:
Her research significance is further underscored by the support it has attracted from major U.S. funding agencies, including the Department of Defense (DoD), the National Institutes of Health (NIH), and the Department of Veterans Affairs (VA). These prestigious funding sources highlight both the national importance and the innovative potential of her contributions.

Recognition and Expert Support:
To strengthen the petition, four recommendation letters were submitted from leading experts in the field. These recommenders emphasized the originality of her discoveries, the clinical implications of her research, and the essential role her work plays in advancing immunotherapy and cancer biology.

“Considering that cancer continues to claim the lives of more patients in the United States every year, there is an immediate and dire need to continue the support of [Client’s] immunology research.”

NIW Approval and Outlook:
By combining an impressive academic record, demonstrated innovation through patent contributions, significant citations, and strong funding support, the petition clearly established that the client is well-positioned to advance her proposed endeavor. Her ongoing research in tumor immunology will directly support U.S. national interests by driving forward the development of more effective cancer treatments and improving patient outcomes.

At NAILG, we are proud to have successfully represented this client and congratulate her on this achievement. We look forward to her continued contributions to immunology and cancer research.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.